Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:antigenStrain |
gptkb:Pitman-Moore_(PM-3211)_strain
|
| gptkbp:approvedBy |
gptkb:World_Health_Organization
|
| gptkbp:contains |
purified Vero cell rabies vaccine
|
| gptkbp:countryOfOrigin |
gptkb:India
|
| gptkbp:form |
lyophilized powder
|
| https://www.w3.org/2000/01/rdf-schema#label |
Rabivax-S
|
| gptkbp:indication |
post-exposure prophylaxis
pre-exposure prophylaxis |
| gptkbp:manufacturer |
gptkb:Serum_Institute_of_India
|
| gptkbp:marketedIn |
gptkb:India
several other countries |
| gptkbp:reconstitution |
sterile water for injection
|
| gptkbp:routeOfAdministration |
intramuscular
|
| gptkbp:shelfLife |
36 months
|
| gptkbp:storage |
2-8°C
|
| gptkbp:targetAudience |
humans
|
| gptkbp:type |
vaccine
|
| gptkbp:usedFor |
rabies prevention
|
| gptkbp:WHOPrequalified |
yes
|
| gptkbp:bfsParent |
gptkb:Serum_Institute_of_India
|
| gptkbp:bfsLayer |
6
|